You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

Suppliers and packagers for DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE


✉ Email this page to a colleague

« Back to Dashboard


DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Actavis Labs Fl Inc DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE doxylamine succinate; pyridoxine hydrochloride TABLET, DELAYED RELEASE;ORAL 205811 ANDA Actavis Pharma, Inc. 0591-2132-01 100 TABLET, DELAYED RELEASE in 1 BOTTLE (0591-2132-01) 2019-06-21
Bionpharma DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE doxylamine succinate; pyridoxine hydrochloride TABLET, DELAYED RELEASE;ORAL 217000 ANDA Bionpharma Inc., 69452-206-20 100 TABLET, DELAYED RELEASE in 1 BOTTLE (69452-206-20) 2023-12-11
Mylan Pharms Inc DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE doxylamine succinate; pyridoxine hydrochloride TABLET, DELAYED RELEASE;ORAL 207825 ANDA Mylan Pharmaceuticals Inc. 0378-4615-01 100 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (0378-4615-01) 2020-07-21
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for the Pharmaceutical Drugs: Doxylamine Succinate and Pyridoxine Hydrochloride

Last updated: July 31, 2025

Introduction

The pharmaceutical landscape features a diverse network of suppliers for active pharmaceutical ingredients (APIs), especially for well-established compounds like Doxylamine Succinate and Pyridoxine Hydrochloride. These compounds serve crucial roles in sleep aid formulations and vitamin B6 supplementation, respectively. Understanding the key suppliers, their global footprints, quality standards, and market influence is vital for pharmaceutical companies, generic drug manufacturers, and healthcare providers aiming to ensure supply chain robustness and regulatory compliance.


Overview of Doxylamine Succinate and Pyridoxine Hydrochloride

Doxylamine Succinate is an antihistamine primarily used as a short-term sleep aid due to its sedative properties. It is also employed in combination therapies for nausea, especially during pregnancy. Its chemical structure features a succinate salt form, enhancing stability and bioavailability.

Pyridoxine Hydrochloride is the hydrochloride salt form of vitamin B6, essential for amino acid metabolism, neurotransmitter synthesis, and hemoglobin production. It is a widely used vitamin supplement and is integrated into multiple multivitamin formulations.

Both APIs fulfill high-demand segments in pharmaceuticals and OTC markets, necessitating a reliable and compliant supply chain.


Leading Global Suppliers for Doxylamine Succinate

  1. Hubei Meihua Biological Technology Co., Ltd.
    Based in China, Meihua is a prominent manufacturer of pharmaceutical ingredients, including Doxylamine Succinate. The company adheres to Good Manufacturing Practices (GMP) and holds relevant certifications from regulatory bodies such as the NMPA (National Medical Products Administration) and GMP accreditation from Europe and the US.

  2. Jiangxi Phalanx Biologicals Co., Ltd.
    Also China-based, Phalanx supplies Doxylamine Succinate APIs globally, emphasizing quality control and consistency. Their facilities comply with international standards, making them a preferred vendor for large-scale pharmaceutical firms.

  3. Kaké Pharma Inc.
    Located in India, Kaké Pharma offers Doxylamine Succinate API with ISO 9001 and WHO-GMP certification, catering mainly to North American and European markets.

  4. Taiwan MVP Pharmaceutical Corporation
    Recognized for high-quality APIs, MVP Pharmaceutical supplies Doxylamine Succinate with strict quality assurance processes, serving clients in North America, Europe, and Asia.


**Leading Global

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.